ideology-health
  • Our Solutions
  • About Us
    • ideology-health
    Privacy Policy
    Terms of Service
    Inc. 5000

    IDEOlogy Health Ranks No. 772 on the 2025 Inc. 5000 Fastest-Growing Private Companies in America

    © 2026 IDEOlogy Health. All product names, logos, brands, trademarks and registered trademarks are property of their respective owners and their use(s) do not necessarily imply endorsement.

    W

    Dr Wade Iams, MD

    Medical professional dedicated to sharing knowledge and insights through educational videos.

    Dr. Wade Iams discusses adverse event prophylaxis strategies for patients with EGFRm mNSCLC on 1L amivantamab subQ + lazertinib (Video 1/3)

    Dr. Wade Iams discusses adverse event prophylaxis strategies for patients with EGFRm mNSCLC on 1L amivantamab subQ + lazertinib (Video 1/3)

    COPERNICUS Design, Efficacy

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on connecting actionable mutations to therapy in lung cancer (Video 3/3)

    Dr. Wade Iams shares his insights on connecting actionable mutations to therapy in lung cancer (Video 3/3)

    PM in Lung – matching therapy to mutation

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on reading an NGS report in lung cancer (Video 2/3)

    Dr. Wade Iams shares his insights on reading an NGS report in lung cancer (Video 2/3)

    Reading an NGS report

    Wade Iams, MD
    Lung Cancer
    Dr. Wade Iams shares his insights on liquid and tissue-based NGS testing in lung cancer (Video 1/3)

    Dr. Wade Iams shares his insights on liquid and tissue-based NGS testing in lung cancer (Video 1/3)

    Liquid NGS background

    Wade Iams, MD
    Lung Cancer